title: Immunobiology of the Tomatine adjuvant.
abstract: Soluble or sub-unit protein vaccines alone are incapable of generating antigen-specific cellular immune responses. This failure can be attributed to the manner in which the immune system processes antigen; endogenous antigens are cycled through the MHC class I pathway to stimulate CD8+ restricted responses and exogenous antigens are processed through the MHC class II pathway to generate humoral immunity. Traditionally sub-unit vaccines have been formulated with adjuvants to enhance immunogenicity, however in the last decade a number of adjuvants have been developed that effectively stimulate the generation of both humoral and cellular immune responses, although the manner in which they exert their effects has not been investigated. Here we describe Tomatine, a glycoalkaloid based adjuvant, capable of stimulating potent antigen-specific humoral and cellular immune responses that contribute to protection against malaria, Francisella tularensis and regression of experimental tumors. Using in vivo models we investigated the manner in which cellular immune responses were generated by Tomatine. We established that Tomatine did not require either lymph node or splenic macrophages to generate cytotoxic T lymphocytes (CTL) and delivered soluble protein into a pathway not dependant on the machinery of the classical MHC class I pathway. We also observed that at the molecular level Tomatine required both CD80 and CD86 costimulation to engender antigen-specific cellular immunity.
authors.affiliation: Department of Pathobiology, Washington National Primate Research Center, University of Washington, 3000 Western Avenue, Seattle, WA 98004, USA. wjwm@u.washington.edu
authors.forename: W J W
authors.initials: WJ
authors.lastname: Morrow
authors.forename: Y-W
authors.initials: YW
authors.lastname: Yang
authors.forename: N A
authors.initials: NA
authors.lastname: Sheikh
mesh_terms: D000276:Adjuvants, Immunologic / Q000008:administration & dosage*; D000818:Animals; D003602:Cytotoxicity, Immunologic; D017780:Malaria Vaccines / Q000276:immunology*; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*; D014053:Tomatine / Q000008:administration & dosage*; D014611:Vaccination
chemical_list: D000276:Adjuvants, Immunologic; D017780:Malaria Vaccines; D014053:Tomatine